Yes, there are prescription weight loss medications that produce significant, measurable results in clinical trials. The most effective options available today can help people lose 10% to 15% of their body weight over roughly a year, with newer drugs pushing even higher. These are not the dubious supplements sold at gas stations. They are FDA-approved medications that require a prescription and work through specific biological mechanisms.
That said, “works” comes with important caveats. Most of these medications need to be taken long-term to maintain results, they come with real side effects, and they aren’t available to everyone. Here’s what the evidence actually shows.
The Medications With the Strongest Evidence
Several FDA-approved medications have been tested in large, rigorous clinical trials. They differ significantly in how much weight they help people lose.
Injectable semaglutide (sold as Wegovy) is currently the most effective single-ingredient option widely available. In a major trial, people taking it lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. That means someone starting at 250 pounds could expect to lose roughly 37 pounds. It works by mimicking a gut hormone called GLP-1, which reduces appetite and slows digestion so you feel full longer.
Tirzepatide (sold as Zepbound) targets two gut hormones instead of one and produces even larger results in head-to-head comparisons, though the data above focuses on semaglutide trials. It’s in the same injectable class and works through similar appetite-reducing pathways.
Phentermine/topiramate (sold as Qsymia) combines an appetite suppressant with a medication originally used for seizures. In trials lasting 56 weeks, people on the higher dose lost about 10.2% of their body weight, compared to 1.4% on placebo. It’s taken as a daily pill and has been available since 2012.
Orlistat (sold as Xenical, or over-the-counter as Alli) works completely differently. Instead of suppressing appetite, it blocks roughly one-third of the fat you eat from being absorbed. At 12 months, people using it lost about 10.2% of their body weight versus 6.3% on placebo. It’s the least dramatic option, but it’s also the only one available without a prescription in its lower-dose form.
How the Newer Drugs Compare to Older Ones
The gap between generations of weight loss medication is substantial. When semaglutide was tested directly against liraglutide (an older GLP-1 drug sold as Saxenda), semaglutide produced 15.8% weight loss compared to 6.4% for liraglutide over 68 weeks. That’s more than double the effect from a drug in the same class.
Liraglutide still outperforms placebo meaningfully. In its own trials, about 63% of people on liraglutide lost at least 5% of their body weight, and a third lost more than 10%. But the newer medications have largely overtaken it in clinical practice.
An oral version of semaglutide is also showing strong results. In a recent trial, a 25 mg daily pill produced 13.6% weight loss at 64 weeks versus 2.2% on placebo. That’s slightly less than the injectable version but close enough that it could become a preferred option for people who don’t want weekly injections.
What the Side Effects Look Like
The GLP-1 drugs (semaglutide, liraglutide, tirzepatide) share a common side effect profile centered on the digestive system. Across a large analysis of 48 clinical trials covering nearly 28,000 participants, the most frequent issues were nausea (affecting about 21% of users), diarrhea (11%), vomiting (9%), and constipation (8%). In the oral semaglutide trial specifically, 74% of participants reported some gastrointestinal issue, though most were mild to moderate and tended to ease after the first few weeks as the dose gradually increased.
Orlistat has its own distinctive side effects tied directly to how it works. Because unabsorbed fat passes through the digestive tract, oily stools, gas, and urgent bowel movements are common, especially after high-fat meals. This acts as a built-in incentive to eat less fat.
Phentermine/topiramate can cause tingling in the hands and feet, dry mouth, constipation, and trouble sleeping. Because phentermine is a stimulant, it can also raise heart rate.
The Weight Regain Problem
This is the biggest caveat with every weight loss medication on the market. A systematic review published in The Lancet found that within one year of stopping a GLP-1 drug, people regained 60% of the weight they had lost during treatment. The medications suppress appetite for as long as you take them, but that effect disappears when you stop.
This means most people need to think of these drugs as ongoing treatment, similar to blood pressure medication, rather than a short course that permanently resets their weight. That has major implications for cost, side effect exposure, and long-term planning.
Who Can Get a Prescription
FDA guidelines set specific thresholds. You’re generally eligible if you have a BMI of 30 or higher, or a BMI of 27 or higher combined with a weight-related health condition like high blood pressure or type 2 diabetes. Your doctor may also consider other factors like previous weight loss attempts and your overall health picture.
Over-the-counter orlistat (Alli) at its lower 60 mg dose is available to any adult without a prescription, though it produces more modest results than the prescription-strength version.
What These Medications Actually Cost
Cost has been the single biggest barrier to access. The list prices for the most effective options have been steep: Wegovy at around $1,350 per month and Zepbound at about $1,086 per month. Many insurance plans haven’t covered them, leaving patients to pay out of pocket.
Pricing is shifting, though. Under a recent federal pricing initiative, Wegovy and Ozempic (the diabetes-branded version of semaglutide) are set to drop to $350 per month through the TrumpRx program, with Zepbound at a similar price point. Medicare beneficiaries would pay a $50 monthly copay. If an oral version of semaglutide receives FDA approval, its initial price through the program would be $150 per month, making it the most affordable effective option.
Older medications are significantly cheaper. Generic phentermine costs as little as $15 to $30 per month, and over-the-counter orlistat runs about $40 to $60 per month, though both are less effective than the newer drugs.
What About Supplements and OTC “Diet Pills”?
The supplements marketed as diet pills in pharmacies, online stores, and social media ads occupy a completely different category from the prescription medications above. Products containing green tea extract, garcinia cambogia, raspberry ketones, or similar ingredients are classified as dietary supplements, not drugs. That means they don’t need to prove they work before going on sale. The FDA only intervenes after a product is found to be unsafe.
No over-the-counter supplement has produced weight loss results remotely comparable to the prescription medications in rigorous clinical trials. Some contain caffeine or other stimulants that mildly suppress appetite, but the effects are small and temporary. The only OTC product with meaningful clinical evidence is orlistat at its lower dose.
What’s Coming Next
The pipeline of weight loss drugs is advancing quickly. A compound called amycretin, which targets GLP-1 and another hormone simultaneously, produced 13% weight loss in just 12 weeks in early human testing with its oral form. An injectable version reduced body weight by 24% at 36 weeks. These are phase 1 results, meaning larger trials are still needed, but the trajectory suggests even more effective options could reach the market within a few years.
The practical significance: today’s most effective medications produce 14% to 15% body weight loss over about a year. The next generation may push well past 20%, potentially in pill form rather than injections, and at lower price points as competition increases.